Class Action News

Class Action Legal News articles include legal news and lawsuit information about lawsuits filed, settlements reached and verdicts rendered in class action cases dealing with personal injury, defective products, bad drugs and other consumer law related news issues. Many of these articles include interviews from top legal professionals with guidance on legal recourse options from losses resulting from bad drugs, medical malpractice, investment fraud, personal injury, defective products and negligent employers.

Endoscopy Hepatitis C: Tragic Stories Are Emerging
March 24, 2008
Las Vegas, NV: Imagine the shock and horror of getting a medical letter addressed to your husband, warning him that he may have contracted hepatitis C from an infected syringe, and recommending he be tested right away.
Bear Stearns: The Deal is Still at Play, Shareholders Fight Back
March 24, 2008
New York, NY: The day after the Bear Stearns bailout was announced at the fire sale price of $2 a share, some longtime Bear Stearns employees were seen in the hallways crying. A third of Bear Stearns employees are also shareholders, and suddenly faced losing their life savings if Bear Stearns fails, or is actually sold at such a low price.
Merck/Schering Tries to Wine and Dine Vytorin Back to Health
March 24, 2008
Kenilworth, NJ Since the results of the ENHANCE clinical tests for Merck/Schering-Plough's Vytorin combination anti-cholesterol drug were released in mid-January, sales of the drug have plunged as much as 17 percent. That's because the ENHANCE results showed that the $3-a-pill Vytorin, which combines Merck's Zetia with generic simvastatin, did no better than inexpensive simvastatin alone at lowering users' arterial plaque, and thus their risk for stroke or heart attack.
Merck & Co. to Pay $4.85 Billion in Personal Injury Cases Due to Vioxx
March 22, 2008
Trenton, N.J. Vioxx is the impetus feeding the fire of over 44,000 personal injury lawsuits being exacted against Pharmaceutical manufacturer Merck & Co. The drug has caused several incidences of heart ailments, strokes, and even cases of death from its side effects. The former painkiller was eliminated from the market in 2004. The 44,000 personal injury cases are just from plaintiffs in the United States. Former patients that used Vioxx in 18 other nations have stepped forward demanding a refund for the money spent on the drug. Also, health care professionals and stockholders in these nations are demanding repayment for the losses they've incurred from the drug going South. Fresh lawsuits from overseas areas continue to come in.
Zetia/Vytorin: "He was a good man and his life was cut short."
March 21, 2008
Parachute, CO: Melissa Cruz's father was diagnosed with diabetes in 1996. That's why today she continues to wonder why in 2002 his doctor prescribed him Merck/Schering-Plough's Zocor, then added Zetia about a year later, and again in 2007—the same combination of anti-cholesterol drugs used in the companies' Vytorin.
Vytorin: "My Heart Attack could have been Prevented"
March 19, 2008
St. George, UT About two years ago, Deloy's doctor prescribed Vytorin to lower his cholesterol. "My doctor was taking it as well so that was good enough for me," says Deloy. "Then I saw ads on TV about how great it was and that reassured me even more—it takes care of what your mum gave you and what your wife gives you." But Vytorin didn't give. In fact, it took.
Bear Stearns: The Bear is Silenced, The Investors Buffaloed
March 18, 2008
New York, NY At news that JP Morgan, with an assist from the Federal Reserve had scooped up beleaguered Bear Stearns at a fire sale for $2 a share over the weekend, the financial world suddenly felt the cold wind that they had been hearing off in the distance for months. But pity the shell-shocked Bear Stearns investor, whose stock was worth $170 dollars a share or more, just a year ago.
Vytorin: "No one could tell me why I had a heart attack."
March 18, 2008
Dalton, GA Until a year ago, Larry Matthews had a normal life in this area near the Georgia-Tennessee border. He was physically active at home and at work, and like many men of a certain age, was keeping an eye on his cholesterol and blood pressure. That was before Vytorin, the combination Zetia/Zocor (simvastatin) anti-cholesterol drug from Merck/Schering-Plough, changed things for the worse.
Hepatitis C in Nevada
March 17, 2008
Las Vegas, NV As is often the case when news of a health violation breaks, the news gets worse before it gets better. Not more than a week after it was revealed that an outpatient clinic in Nevada had been investigated with regard to six cases of hepatitis C potentially caused by the re-use of syringes, comes news that the patients of six other centers may be at risk.
Vytorin: Yet Another Consumer Complaint
March 13, 2008
Lafayette, LA Imagine taking a drug that costs about three times more than similar medications, doesn't work and even does more harm than good. Colin G. doesn't have to imagine: he took Vytorin and is suffering the consequences. He wonders how drug makers could fraudulently market a drug and put people's lives at risk.
Amgen's Anemia Triple Threat: Black Box Warnings Expanded
March 8, 2008
New Brunswick, NJ A new black box warning announced yesterday by anemia drug maker Amgen comes on the heels of recent data which suggests increased incidence of death, and accelerated tumor growth amongst patients with certain types of cancer.
Menu Foods: "It was a Slow Death"
March 5, 2008
Long Island, NY "Spunky, our Miniature Schnauzer, started to get sick and stopped acting his name," says Helen. "Our vet did some tests and found that his liver and kidney enzymes kept fluctuating so he gave us a few prescriptions, but he never got better." Sadly, Spunky passed away a few months before the Menu Foods recall.
Woman Suspicious of Vytorin's Side Effects
March 4, 2008
Lake Havasu City, AZ Liz has always harbored suspicions about medications she could not substantiate and sitting at the top of her list is Vytorin, the cholesterol-lowering drug she has taken for five years.
Vytorin - A Costly Risk
March 3, 2008
Clarksville, IN The cost of Vytorin, a cholesterol-lowering drug, is taking such a chunk out of Jack's monthly budget he is reduced to begging for samples. But beyond the financial strain, he is also beginning to worry about its long term effect on his health.
Vytorin: High Priced Dud Accused of False Advertising
March 3, 2008
Jacksonville, FL This is the story of a drug company, like most other drug companies, that appears to put the profits ahead of the people. At least, that's the accusation coming from a dear, old 72-year-old grandmother who is serving as the lead plaintiff for a potential class-action lawsuit against the makers of Vytorin.
Improved Instructions for Nobel Direct Dental Implants
March 3, 2008
Stockholm, Sweden In October 2007, Nobel Biocare issued a safety notice after evaluating more than 2000 Nobel Direct dental implants involved with 1183 patients. Some patients were seen as having a lower-than-marginal bone level and the company concluded that the implants were not placed according to "the intended protocol."
Cell Phone Termination Fees: "A Lot of Money"
March 2, 2008
Fort Dodge, IA: Karen C. (not her real name) says she did everything that Sprint customer service representatives told her to do. She says she was even told that when she moved, she would not be charged an early termination fee. However, she was charged a fee of $1,000, and she says every time she phones Sprint, she speaks to a new customer service representative, who gives her different answers to her questions.
Vytorin: Good for Absolutely Nothing
February 29, 2008
New York, NY "My doctor had me on Zetia and Zocor then I switched to Vytorin when it came on the market," says Jeffrey Aaronson. "Every month I spent $200 on this drug and all I got were nasty side effects." He also got two more heart attacks. Aaronson believes that he was duped into taking Vytorin because of the company's fraudulent marketing, even after it knew that Vytorin (and Zocor) had no effect in preventing plaque buildup in the arteries.
Death Risk from Anemia Drugs, New Study Suggests
February 27, 2008
Chicago, IL While the jury is still out on the ultimate safety of anemia drugs Procrit and Aranesp, and the potential dangers they allegedly pose for cancer patients, new data from a meta analysis to be published today in the Journal of the American Medical Association (JAMA) suggests the jury will remain aloof for at least another few weeks.
Cell Phone Termination Fees: "Don't Give Them the Money"
February 27, 2008
Palominas, AZ Like many other cell phone customers, Charles G. thought his contract had expired and become month-to-month when he decided to cancel his service. He had his two year contract with Sprint for three and a half years and had not made any changes to either his phone or his plan. So, he naturally assumed that he could now cancel his contract at any time without paying cell phone early termination fees.

Page 16 of 25 1 «10 14 151617 18 25 »

Request Legal Help

Please complete this form to request a review of your complaint by an attorney.

First name Last name Email address Phone number Zip Defendant (who are you accusing?) Describe your complaint: Category that best suits your complaint Receive our weekly newsletter from our sister publication LawyersandSettlements with the latest lawsuit news and legal information.

By submitting this form I agree to the Terms of Service.

There is absolutely no cost to you to submit this form. Doing so places you under no obligations and does not establish an attorney-client relationship.

Visit other Online Legal Media Websites: